Jingyuan Zhang

Jul 21, 2024 | mdpi.com | Yameng Xu |Jingyuan Zhang |Wilson Z. Ray |Matthew R. MacEwan

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

May 7, 2024 | pubs.rsc.org | Jingyuan Zhang |Zhen Ma |Lanqi Wang |Edwards Limited

N/P-doped NiFeV oxide nanosheets with oxygen vacancies as an efficient electrocatalyst for the oxygen evolution reaction† Plasma treatment as an effective strategy can simultaneously achieve surface modification and heteroatom doping. Here, an N/P-doped NiFeV oxide nanosheet catalyst (N/P-NiFeVO) constructed by Ar/PH3 plasma treatment is used to drive the oxygen evolution reaction (OER).

Apr 10, 2024 | biorxiv.org | Christian Montès |Jingyuan Zhang |Trevor M. Nolan |Justin Walley

AbstractRecently, major advances have enabled the exploration of cellular heterogeneity using single-cell proteomics. Here we explore the feasibility of single-cell proteomics on plant samples. We focus on Arabidopsis thaliana, examining isolated single cells from the cortex and endodermis, which are two adjacent root cell-types derived from a common stem cell. From 756 cells we identify 3,751 proteins and 1,114 proteins/cell.

Mar 7, 2024 | mdpi.com | Ke Yu |Jingyuan Zhang |Yuting Hu |Lanqi Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jan 1, 2024 | jitc.bmj.com | Byun HK |Ning Jiang |Jingyuan Zhang |Zhen Guo

Clinical/translational cancer immunotherapy Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service.